In a systematic review, researchers observed the effect of disease-modifying drug treatment in postpartum women with relapsing multiple sclerosis.
Using the Expanded Disability Status Scale and 25-foot walk times, researchers examined motor performance for upper and lower extremities in patients with multiple sclerosis at a registry enrollment.
Researchers sought to understand the most challenging symptoms experienced by patients with multiple sclerosis and the importance of symptom management in this population group.
Researchers sought to determine the status of neurologic assessment and magnetic resonance imaging compared with the Timed 25-Foot Walk test, a clinical tool that measures quantitative mobility and leg function performance, in patients with multiple sclerosis.
Researchers sought to compare the frequency, racial differences, neurologic phenotype, and outcome of attacks that required ventilator support in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Researchers sought to determine the T-cell and antibody response to the SARS-CoV-2 vaccine in patients with multiple sclerosis treated with ocrelizumab, compared with healthy individuals.
Ublituximab is an investigational glycoengineered anti-CD20 monoclonal antibody.
Using a retrospective matched cohort design, researchers determined whether overall and cancer-specific survival following a colorectal cancer diagnosis is lower in patients with multiple sclerosis (MS) than without MS.
Researchers sought to evaluate the safety and treatment outcomes of ocrelizumab, a humanized anti-CD20 immunoglobulin G antibody, in patients with multiple sclerosis.
Researchers determined the impact of other disease-modifying treatments in multiple sclerosis and the effect of delaying anti-CD20 infusion on the humoral response to COVID-19 vaccines.
Using neurite orientation dispersion and density imaging, researchers investigated the presence of early microstructural damage and its link with physical disability and white matter lesion volume within tracts in pediatric patients with multiple sclerosis.
In a meta-analysis, researchers analyzed the effects of probiotics on disease progression, depression, general health, and anthropometric measures in patients with relapsing remitting multiple sclerosis.
A team of researchers assessed the long-term safety and efficacy of dimethyl fumarate for the treatment of patients with relapsing remitting multiple sclerosis for up to 13 years.
This cross-sectional study assessed the frequency of peripapillary hyper-reflective ovoid masslike structures, a novel finding in retinal optical coherencetomography, in patients with early relapsing remitting MS and its link to disease duration in MS subtypes.
Researchers measured cognitive impairment conversion in patients with MS to better understand how it relates to changes in functional connections in structured brain regions.
Researchers compared the effect of high-efficacy DMTs and treatment escalation with regard to the reduction of confirmed disability worsening rates in relapsing-remitting multiple sclerosis.
Purified Cortrophin Gel is a purified adrenocorticotropic hormone.
A team of investigators sought to understand COVID-19 characteristics in people with multiple sclerosis and identify high-risk patients.
The American Academy of Neurology Institute released a 2020 quality measurement set to improve care outcomes for patients with multiple sclerosis.
Study researchers evaluated the diagnostic and prognostic value of myeloid microvesicles as multiple sclerosis biomarkers in the clinical setting.
Study investigators evaluated the value of integrating structural and functional network MRI measures to predict clinical disability deterioration of multiple sclerosis.
Study researchers assessed the long-term disability risk following pregnancy in women with multiple sclerosis.
A team of researchers surveyed patients with multiple sclerosis to determine if influenza vaccine uptake would not meet public health targets.
In this editorial, study researchers discussed the possible prodromal phase of multiple sclerosis and its role in the early diagnosis of the disease.
This editorial report explored a population-based cohort study on depression and anxiety in pregnant patients with MS.
Study researchers assessed the morphometric and microstructural gray matter differences between primary progressive and relapsing remitting multiple sclerosis.
Study investigators used the visual pathway to assess the promyelinating and neuroprotective effects of alemtuzumab in multiple sclerosis.
Study researchers examined the different paradigms on the pathophysiology of MS, the outside-in and the inside-out theories.
A team of investigators sought to determine whether κ- and λ-FLC index may predict early multiple sclerosis disease activity independent of demographics, clinical, and MRI characteristics.
Researchers called for effective tools for earlier identification of secondary progressive MS to improve long-term outcomes in patients with the disease.